Ranitidine bismuth citrate
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171982This classification denotes a histamine-2 receptor antagonist with the molecular formula C13H22N4O3S.C6H5O7.Bi, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7AJ51I17KG, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3(+)) salt (1:1), compd. with n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n-methyl-2-nitro-1,1-ethenediamine (1:1) but more generally known as ranitidine bismuth citrate, which bears US NIH Compound Identifier 3033887. European Medicines Agency schedules Ranitidine bismuth citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15106MIG. World Health Organization schedules ranitidine bismuth citrate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ranitidine bismuth citrate under HS 29321900 and SITC 51569. As of Q4 2014, RANITIDINE BISMUTH CITRATE remains the US FDA Preferred Term for this commodity. Ranitidine bismuth citrate bears US NLM identifiers UMLS ID C0139919 and NCI Concept Code C66505. SMILES: CNC(=C[N+](=O)[O-])NCCSCC1CCC(O1)CN(C)C.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[BI+3].
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.